Previous Article | Next Article 
Journal of Clinical Microbiology, September 2005, p. 4918-4919, Vol. 43, No. 9
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.9.4918-4919.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Wide Dissemination of a Carbapenemase Plasmid among Gram-Negative Bacteria: Implications of the Variable Phenotype

LETTER
Broad-spectrum carbapenem antibiotics are the last bastion of
empirical therapy for resistant gram-negative bacterial infections,
and outbreaks of carbapenem-resistant bacterial infection may
be associated with greatly increased mortality in the critically
ill (
4). Carbapenems (e.g., imipenem, meropenem, ertapenem)
are increasingly threatened by dissemination of metallo-ß-lactamases
(MßLs), the most important of which are the integron-borne
members of the VIM and IMP families. Integrons are genetic elements
able to capture and express antibiotic resistance determinants
in the form of gene cassettes via site-specific recombination
(
7). Class 1 integrons are dominant among the four classes associated
with antibiotic resistance, and plasmids are important vectors
for their transmission between bacteria in the hospital environment.
While transmissible MßLs are increasingly reported
throughout Asia, Europe, and South America, Australia has only
recently observed the emergence of an MßL, IMP-4 (
5).
We found the
blaIMP-4 gene cassette as the first of four in
a class 1 integron-associated array (GenBank accession no.
AJ609296),
which also includes an
aacA4 gene cassette conferring resistance
to gentamicin and tobramycin. This array was present on a large
conjugative plasmid (pJIBE401) in a clinical isolate of
Klebsiella pneumoniae (Kp1239) referred to our laboratory (
2).
With the arrival of a new gene or set of genes in the gram-negative microflora, it is necessary to determine both its transmissibility characteristics and the resulting phenotype to understand the threat it poses. This means assessing the efficiency of transmission and the host range of the transmissible trait, as well as defining the relevant antibiotic resistance phenotype and any potential disadvantage to the organism in terms of growth characteristics or biological fitness (that is, the chance of being segregated out of the microflora by failing to compete in the absence of selection pressure). We therefore mated Kp1239 with rifampin-resistant recipient strains generated from a range of wild-type enteric bacteria, performing conjugation experiments as previously described (1). Transmission of blaIMP-4-bearing plasmid pJIBE401 from Kp1239 into Escherichia coli (EcUB5201Rf) and Enterobacter aerogenes (Ea13048Rf) occurred at a frequency of 102, while transmission into Citrobacter freundii (Cf4000Rf) and K. pneumoniae (Kp13883Rf) occurred at frequencies of 106 and 107, respectively. Serratia marcescens (Sm1002Rf) transconjugants were also generated, at frequencies of
109 (Table 1). Attempts to introduce pJIBE401 from Kp1239 into Acinetobacter baumannii and Pseudomonas aeruginosa were repeatedly unsuccessful.
Since the detection of Kp1239, we have observed
blaIMP-4 in
a number of other enteric bacteria isolated from patients within
our region. The clinical isolates
K. pneumoniae Kp1239 and Kp2730,
Enterobacter cloacae El3518, and
Citrobacter amalonaticus Ca3927
are all temporally and geographically distinct and readily separated
by DNA fingerprinting (enterobacterial repeat intergenic consensus
sequence typing; data not shown) (
6). These isolates were used
for conjugation experiments into EcUB5201
Rf (Table
2). All appeared
to have a common high-molecular-weight plasmid of the same size
as pJIBE401 (>150 kb; data not shown) carrying identical
gene cassettes, consistent with that plasmid's widespread dissemination.
MICs were determined by Vitek 2 AST-N019 gram-negative susceptibility
card (Vitek AMS; BioMérieux Vitek Systems Inc., Hazelwood,
Mo.), except for imipenem, which was determined by Etest (AB
BIODISK, Solna, Sweden). Most
blaIMP-4-bearing transconjugants
expressed resistance below the Clinical and Laboratory Standards
Institute clinical breakpoint for imipenem sensitivity (Table
1), and we therefore tested whether we could induce higher-level
resistance in these strains upon antibiotic exposure in vitro.
Kp2730, an imipenem-intermediate (MIC, 8 µg ml
1)
clinical isolate, was compared with Kp13883
Rf/pJIBE401 transconjugants,
which were imipenem sensitive (MIC, 3 µg ml
1; Table
1). Kp2730 (but not Kp13883
Rf/pJIBE401) grew as isolated colonies
on nutrient agar (Difco) containing 16 µg ml
1 of
imipenem, occurring at a frequency of 10
1 to 10
2.
A loopful of these colonies was amplified in nutrient broth
(Difco) with 16 µg ml
1 of imipenem and further
subcultured on 64 µg ml
1 of imipenem in nutrient
agar with a 10
1 to 10
2 yield of isolated colonies
again (compared with growth on nonselective medium). A loopful
of the highly resistant Kp2730-derived mutants (Kp2730
R, obtained
from the plates containing 64 µg ml
1 of imipenem)
was resuspended in nutrient broth, and 100 CFU each of these
and of Kp1239, Kp2730, Kp13883
Rf, and KP13883
Rf/pJIBE401, at
log phase, was used to inoculate separate aerobic Bactec 9000
blood culture bottles (BD Diagnostics). All bottles signaled
as positive after overnight incubation, with no significant
difference in growth rates (Kp1239 and Kp2730 bottles signaled
positive at 10 h; Kp13883
Rf, KP13883
Rf/pJIBE401, and Kp2730
R at 11 h), and the high imipenem MICs (

64 µg ml
1)
persisted on subculture.
Decreased outer membrane permeability is one logical explanation for the high carbapenem MICs for some Klebsiella and Enterobacter strains (Tables 1 and 2), but the Kp2730R mutants have not yet been examined in detail. The integron promoter remained unchanged in Kp2730R, and EcUB5201Rf transconjugants displayed little difference in carbapenem MICs as determined by Etests (data not shown), indicating the lack of plasmid involvement in the increased resistance seen. However, ompK36 encodes a porin of known relevance to carbapenem resistance in Klebsiella (3) and we have found this to be disrupted by an insertion sequence in Kp1239 (our unpublished data). Thus, we conclude that a broad-host-range plasmid carrying blaIMP-4 and aacA4 is efficiently transmitted to a wide variety of gram-negative bacteria, that efficiency presumably varying both within and between species, resulting in an elevated MIC of carbapenems which is often still in the sensitive range, but from which stable high-level resistance can be readily selected, at least in some K. pneumoniae strains. This occurs without an obvious growth defect in optimal media and is likely to be clinically important.
The efficient horizontal transfer of resistance genes between gram-negative bacteria in the face of intensive selection pressure in hospitals poses a great problem. The conditional nature of resistance phenotypes such as we describe further complicates infection control measures. Detection of these independent bacterial isolates over the past year suggests dissemination throughout our microflora of a newly arrived panresistance to the main ß-lactams and aminoglycosides. This is a reminder that we need to manage gram-negative resistance surveillance thoughtfully and that we need to think of outbreaks in terms of the transmitted unit (typically a plasmid) and the vagaries of its host range and phenotype.
(These data were presented in part at the Annual Scientific Meeting of the Australian Society for Microbiology, Sydney, Australia, 2004.)

ACKNOWLEDGMENTS
None of the authors have a commercial interest or any other
association that might pose a conflict of interest.
B.E. is supported by an Australian Postgraduate Award.

REFERENCES
1 - Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol. 179:538-540.[Abstract/Free Full Text]
2 - Espedido, B., and J. R. Iredell. Submitted for publication.
3 - Hernandez-Alles, S., V. J. Benedi, L. Martinez-Martinez, A. Pascual, A. Aguilar, J. M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.[Abstract/Free Full Text]
4 - Playford, E. G., J. C. Craig, J. Simpson, and J. R. Iredell. 2003. Abstracts of the 43rd Interscience Conference on Antimicrobial Agents Chemotherapy, abstr. K711. American Society for Microbiology, Washington, D.C.
5 - Poirel, L., J. N. Pham, L. Cabanne, B. J. Gatus, S. M. Bell, and P. Nordmann. 2004. Carbapenem-hydrolysing metallo-ß-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia. Pathology 36:366-367.[CrossRef][Medline]
6 - Rodriguez-Barradas, M., R. Hamill, E. Houston, P. Georghiou, J. Clarridge, R. Regnery, and J. Koehler. 1995. Genomic fingerprinting of Bartonella species by repetitive element PCR for distinguishing species and isolates. J. Clin. Microbiol. 33:1089-1093.[Abstract]
7 - Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3:1669-1683.[Medline]
| | | | | |
Björn Espedido
Jonathan Iredell*
Lee Thomas
Centre for Infectious Diseases and Microbiology Westmead Hospital, University of Sydney Sydney, New South Wales, Australia 2145
Anna Zelynski
Institute for Clinical Pathology and Medical Research Westmead Hospital Westmead, New South Wales, Australia 2145
|
| | | | | |
* Phone: 61 2 9845 6255, Fax: 61 2 9891 5317, E-mail: joni{at}icpmr.wsahs.nsw.gov.au |
Journal of Clinical Microbiology, September 2005, p. 4918-4919, Vol. 43, No. 9
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.9.4918-4919.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A.
(2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev.
22: 664-689
[Abstract]
[Full Text]
-
van Hal, S. J., Wiklendt, A., Espedido, B., Ginn, A., Iredell, J. R.
(2009). Immediate Appearance of Plasmid-Mediated Resistance to Multiple Antibiotics upon Antibiotic Selection: an Argument for Systematic Resistance Epidemiology. J. Clin. Microbiol.
47: 2325-2327
[Abstract]
[Full Text]
-
Liu, Y., Zhang, B., Cao, Q., Huang, W., Shen, L., Qin, X.
(2009). Two Clinical Strains of Klebsiella pneumoniae Carrying Plasmid-Borne blaIMP-4, blaSHV-12, and armA Isolated at a Pediatric Center in Shanghai, China. Antimicrob. Agents Chemother.
53: 1642-1644
[Abstract]
[Full Text]
-
Espedido, B. A., Partridge, S. R., Iredell, J. R.
(2008). blaIMP-4 in Different Genetic Contexts in Enterobacteriaceae Isolates from Australia. Antimicrob. Agents Chemother.
52: 2984-2987
[Abstract]
[Full Text]
-
Zong, Z., Partridge, S. R., Iredell, J. R.
(2008). RmtC 16S rRNA Methyltransferase in Australia. Antimicrob. Agents Chemother.
52: 794-795
[Full Text]
-
Queenan, A. M., Bush, K.
(2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev.
20: 440-458
[Abstract]
[Full Text]
-
Espedido, B. A., Thomas, L. C., Iredell, J. R.
(2007). Metallo-{beta}-Lactamase or Extended-Spectrum {beta}-Lactamase: a Wolf in Sheep's Clothing. J. Clin. Microbiol.
45: 2034-2036
[Abstract]
[Full Text]